Back to results
US 2004/0023977 A1Published application
Process for making substituted thiazolyl-amino pyrimidinyl
OwnerRobert D. Larsen, Anthony On-Ping Kinginventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to a process for preparing substituted thiazolyl-amino pyrimidinyl piperazines, which are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases.
Claims7
A process for preparing substituted thiazolyl-amino pyrimidinyl piperazines of Formula I:
- 14
- wherein
- R is H, (C1-C6)alkyl, (C0-C6)alkyl-NRaRb, or (C0-C6)alkyl-C(O)N(Re)2;
- R1 is H, or unsubstituted or substituted (C1-C6)alkyl;
- R6 is independently selected from H, phenyl, halogen, CN, and pyridyl, said phenyl and pyridyl optionally substituted with one to three substituents selcted from R7;
- R7 is independently selected from:
- 1) Or(C═O)SNRaRb,
- 2) (C═O)rOsaryl,
- 3) (C═O)rOs-heterocyclyl,
- 4) halogen,
- 5) OH,
- 6) O(C1-C3)perfluoroalkyl,
- 7) (C1-C3)perfluoroalkyl,
- 8) (C═O)rOs(C1 C6)alkyl,
- 9) CO2H,
- 10) CN,
- 11) (C1-C6)alkyl-NRaRb, and
- 12) (C1-C6)alkyl-heterocyclyl, wherein r and s are independently 0 or 1, and said aryl, heterocyclyl and alkyl are optionally substituted with one to three substituents selected from Rd;
- Ra and Rb are independently:
- 1) H,
- 2) (C═O)r(C1-C10)alkyl,
- 3) S(O)2Rc,
- 4) (C═O)rheterocyclyl,
- 5) (C═O)raryl, and
- 6) CO2RC,
- wherein r is 0 or 1 and said alkyl, heterocyclyl, and aryl optionally substituted with one or more substituents selected from Rd;
- Rc is independently selected from (C1-C6)alkyl, aryl, and heterocyclyl;
- Rd is independently selected from:
- 1) (C═O)rOS(C1-C10)alkyl, wherein r and s are independently 0 or 1, optionally substituted with up to three substituents selected from OH, (C1-C6)alkoxy, halogen, heterocyclyl, CN, oxo, N(Re)2 and S(O)2Rc,
- 2) Or(C1-C3)perfluoroalkyl,
- 3) (C0-C6)alkylene-S(O)mRc, wherein m is 0, 1, or 2,
- 4) OH,
- 5) halo,
- 6) CN,
- 7) (C0-C6)alkylene-aryl, optionally substituted with up to three substituents selected from Re,
- 8) (C0-C6)alkylene-heterocyclyl, optionally substituted with up to three substituents selected from Re,
- 9) C(O)Rc,
- 10) CO2Rc,
- 11) C(O)H,
- 12) N(Re)2, and
- 13) CO2H;
- Re is independently selected from:
- 1) H,
- 2) (C1-C6)alkyl, optionally substituted with one or more substituents selected from OH, heterocyclyl, (C1-C6)alkoxy, halogen, CN, oxo, N(Rf)2 and S(O)2Rc,
- 3) aryl, optionally substituted with one or more substituents selected from OH, heterocyclyl, (C1-C6)alkoxy, halogen, CN, N(Rf)2 and S(O)2Rc,
- 4) heterocyclyl, optionally substituted with one or more substituents selected from OH, heterocyclyl, (C1-C6)alkoxy, halogen, CN, oxo, N(Rf)2 and S(O)2Rc, and
- 5) S(O)2Rc;
- said heterocycle optionally substituted with one or more substituents selected from OH, (C1-C6)alkoxy, halogen, CN, oxo, N(Rf)2 and S(O)2Rc;
- and
- Rf is independently selected from H, aryl and (C1-C6)alkyl;
- which comprises the steps of:
- a) reacting a compound of Formula II
- 15
- with a compound of Formula III
- 16
- (wherein X is halo), to provide a compound of Formula IV
- 17
- b) reacting the compound of Formula IV with a compound of Formula V
- 18
- c) isolating the compound of Formula I.
57 more elements
A process for preparing 2-(4-{6-[(5-cyano-1,3-thiazol-2-yl)amino]pyrimidin-4-yl}piperazin-1-yl)-N-isopropylacetamide
- 19
- which comprises the steps of:
- a) adding 2-amino-5-cyanothiazole, dichloropyrmidine, and K3PO4 to DMF to provide 2-[(6-chloropyrimidin-4-yl)amino]-1,3-thiazole-5-carbonitrile;
- b) adding 2-[(6-chloropyrimidin-4-yl)amino]-1,3-thiazole-5-carbonitrile and triethylamine to N-Isopropyl-2-piperazin-1-ylacetamide in n-butanol;
- and
- c) isolating 2-(4-{6-[(5-cyano-1,3-thiazol-2-yl)amino]pyrimidin-4-yl} piperazin-1-yl)-N-isopropylacetamide.
3 more elements
Dependencies are inferred from the claim text.